re: Ivermectin: Cancer killer Are you aware of these studies?

quote:

---

A ball of tightly wound parasites protected in biofilm that they biopsy and spread.

---

I look at cancer under the microscope every day and have never seen what you are describing.

I love this board

quote:

---

Bc they stopped teaching y’all about parasites when Rockefeller took over medical schools.

---

Yeah ok.

quote:

---

A ball of tightly wound parasites protected in biofilm that they biopsy and spread.

---

What about leukemia?

quote:

---

It is proven to help with Covid.

---

As a part of a drug “cocktail” it showed benefits.

By itself, the anecdotal data (everything else was buried), it seemed to be effective as a preemptive measure.

Iirc, NAC was also (temporarily) removed by the FDA (some weird shite about reviewing their request for approval that they had put forth many decades earlier).
The irony, they pivoted all those decades ago to be a supplement (I believe it’s simply an amigo acid). It has been shown to help with respiratory issues.

The timing of NAC being “targeted” is odd to say the least.

You really are all about Facebook aren’t you?

I don’t go there for a reason. You should take a break from it and explore the world outside of social media and network news.

You might learn some new things and perhaps become reasonable and less hostile.

Maybe you will live longer and not be in danger of someone tricking you into taking Ivermectin.

quote:

---

 I do not believe you will find any trials in cancer patients that show a significant response rate.

---

ChatGPT sheds some light on why it is highly unlikely there will ever be clinical trials for ivermectin/cancer.

quote:

---

The financial barriers for ivermectin in regard to clinical trials primarily stem from its status as an off-patent drug. Here are some key points:

1. Lack of Profit Motivation: Ivermectin is off-patent and has been widely available for decades. This means that pharmaceutical companies do not have exclusive rights to its production, so there is little financial incentive for them to fund costly clinical trials to explore new uses, such as cancer treatment. Since ivermectin is inexpensive, there is little potential for large profits from its commercialization in new applications.

2. Limited Funding from Industry: Pharmaceutical companies typically fund clinical trials for drugs that have the potential for significant profits, either through exclusivity or high demand. As ivermectin is already generic and widely accessible, there is minimal commercial interest from drug companies in funding large-scale clinical trials for its use in conditions like cancer.

3. Government and Nonprofit Funding: Although government agencies and nonprofit organizations sometimes fund trials for off-patent drugs, this funding is limited. Clinical trials, especially large ones, are expensive, and the priority for public funding typically goes to newer drugs or more pressing health concerns. For ivermectin to be tested in new areas, such as cancer treatment, public or academic institutions would have to secure funding through grants or other means, but this is often challenging.

4. Regulatory Challenges: Clinical trials, particularly those investigating new uses for established drugs, can face significant regulatory hurdles. For example, demonstrating efficacy in cancer treatment would require a series of complex trials with large sample sizes, extensive data collection, and long follow-up periods. This adds additional costs and requires a substantial commitment of resources, which can be difficult to sustain without significant financial backing.

5. Competing Research Priorities: There are many other potential cancer treatments that attract more attention and funding from both the private and public sectors. The competition for research dollars, combined with the financial risks of testing a repurposed drug like ivermectin, often pushes new investigations for such drugs to the backburner.

In summary, the key financial barrier is that ivermectin lacks commercial appeal as a drug for new indications due to its low cost and off-patent status, limiting the funds available for conducting large-scale, well-funded clinical trials.

---

quote:

---

The ones who were right the past 5 yrs have more credibility than those in the medical industry who lied about everything.

---

I really don't know, that's why I am asking, but has it been proven that Ivermectin works against COVID better than the vaccine?

From what I understand the initial vaccine does not work against today's COVID. I got COVID for the first time at the beginning of the year and I was pretty sick. My medical care provider (np not the doctor) told me that she could prescribe me Paxlovid, but it was pointless because you have to take it early and that by the time most people find out they have COVID its too late.

I didn't even think about Ivermectin, but again.. I don't know who was right or who was wrong, I am not just going to trust just a random person who tells me "take Ivermectin. It works". I will research it myself, look at as much information as possible and make my own decision especially when someone who isn't a medical professional recommends taking something.

That's the problem with all of this. Who do we trust? My instinct is to not trust anyone, but we live in a crazy time. We have access to all the information in the world, yet you don't know who to trust.

quote:

---

What about leukemia?

---

Yes. Flukes.

quote:

---

I know what a parasite looks like under the micrscope, clown

---

BS. Labs results come back negative for parasites when people are infested.

Education does equate to knowledge bc you don’t know what you never learned.